Evogene Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.3
- Dividend yield
- –
About Evogene
Agricultural Chemicals, SIC 2870
Evogene Ltd. is a computational biology company that develops products for life science markets. The company operates through specialized subsidiaries focused on agriculture, human health, and industrial applications, including AgPlenus, Biomica, Casterra Ag, and Lavie Bio. Evogene's offerings encompass agricultural biologicals, microbiome-based therapeutics, ag-chemicals, and castor seed solutions, addressing the needs of agricultural producers, industrial partners, and healthcare entities.
The company conducts business activities across international markets, with operations and collaborations spanning the United States, Israel, Europe, and Africa. Evogene maintains research and development facilities comprising specialized laboratory spaces and office facilities. Evogene Ltd. is incorporated in Israel and maintains its principal executive offices in Rehovot, Israel.
Summary of the business section of Evogene's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Evogene Ltd.
- Headquarters
- Rehovot, L3
- Address
- 13 Gad Feinstein Street, Park Rehovot 7638517
- Phone
- 97289311900
- Website
- evogene.com
- Employees
- 78, Dec 31, 2025
- Industry
- Agricultural Chemicals
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- KOST FORER GABBAY & KASIERER, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- EVGN
- Exchange
- Nasdaq
- IPO date
- Nov 22, 2013
- Shares outstanding
- 9M, Dec 31, 2025
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-10 reverse, Sep 16, 2024; 1-for-10 reverse, Jul 25, 2024
- SEC CIK
- 1574565
- CUSIP
- M4119S187
- ISIN
- USM4119S1879
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Ofer Haviv | President and CEO, Director | – |
| Gabi Tarcic | Chief Development Officer | 1,129 |
| Polina Ravzin | VP Finance | – |
| Yaron Eldad | Chief Financial Officer | 4,100 |
| Ilia Zhidkov | Chief Technology Officer | – |
| Leon Recanati | Director | 1,343,886 |
| Nir Nimrodi | Director | – |
| Dan Michael Falk | Director | – |
| Adrian John Percy | Director | – |
| Sarit Firon | Director | – |
Employees
Headcount reported in annual reports
“The Companies Law codifies the fiduciary duties that office holders owe to a company. Many of the executive officers listed in the table under “Item 6. Directors, Senior Management and Employees— … 78”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Dec 29, 2016 | Delisting | Notice of delisting from exchange (Form 25) |
| Dec 29, 2016 | Listing | Registration of securities on an exchange (Form 8-A) |
| Nov 22, 2013 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 8, 2013 | Listing | Registration of securities on an exchange (Form 8-A) |